tradingkey.logo
搜索

Champions Oncology Inc

CSBR
添加自选
5.960USD
-0.085-1.41%
收盘 07/02, 13:00美东报价延迟15分钟
82.77M总市值
亏损市盈率 TTM

Champions Oncology Inc

5.960
-0.085-1.41%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.41%

5天

-2.93%

1月

+2.05%

6月

-10.51%

今年开始到现在

-13.75%

1年

-17.34%

关键数据
5.980今开
6.090最高
4.31K成交量
亏损市盈率 TTM
58.08市盈率动
--股息TTM
0.03%换手率
6.045昨收
5.850最低
14.70K成交额
17.61市盈率静
19.32市净率
0.00%股息率 TTM
-7.93%ROA
9.63052周最高
1.19量比
4.70M净利润
13.89M总股本
-0.1725每股收益TTM
0.40Beta
-48.05%ROE
5.50052周最低
3.97%振幅
46.65%毛利率
82.77M总市值
1.57回报/风险
3.97%风险率

TradingKey Champions Oncology Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Champions Oncology Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名195/387位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价12.00。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Champions Oncology Inc评分

相关信息

行业排名
195 / 387
全市场排名
355 / 4564
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Champions Oncology Inc亮点

亮点风险
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
业绩增长期
公司处于发展阶段,最新年度总收入56.94M美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值低估
公司最新PE估值-35.04,处于3年历史低位
机构减仓
最新机构持股6.66M股,环比减少5.85%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00

分析师目标

根据 0 位分析师
--
评级
12.000
目标均价
+109.42%
涨幅空间

Champions Oncology Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Champions Oncology Inc简介

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
公司代码CSBR
公司Champions Oncology Inc
CEOBrainin (Robert)
网址https://championsoncology.com

常见问题

Champions Oncology Inc(CSBR)的当前股价是多少?

Champions Oncology Inc(CSBR)的当前股价是 6.08。

Champions Oncology Inc的股票代码是什么?

Champions Oncology Inc的股票代码是CSBR。

Champions Oncology Inc股票的52周最高点是多少?

Champions Oncology Inc股票的52周最高点是9.63。

Champions Oncology Inc股票的52周最低点是多少?

Champions Oncology Inc股票的52周最低点是5.50。

Champions Oncology Inc的市值是多少?

Champions Oncology Inc的市值是83.95M。

Champions Oncology Inc(CSBR)股票的每股收益(EPS TTM)是多少

Champions Oncology Inc(CSBR)股票的每股收益(EPS TTM)是0.34。